Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|July 9, 2024
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cellsBrandon J Sytsma, Vincent Allain, Struan Bourke, et al.Nature Biomedical Engineering|May 5, 2023
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytesDana V Foss, Joseph J Muldoon, David N Nguyen, et al.Biorxiv : the Preprint Server for Biology|October 3, 2025
In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumorsQi Liu, Peixin Amy Chen, Esha Urs, et al.Communications Biology|February 23, 2019
A large CRISPR-induced bystander mutation causes immune dysregulationDimitre R Simeonov, Alexander J Brandt, Alice Y Chan, et al.Cell Reports|May 10, 2012
A resource for the conditional ablation of microRNAs in the mouseChong Yon Park, Lukas T Jeker, Karen Carver-Moore, et al.The Journal of Clinical Investigation|January 25, 2022
Microbial signals, MyD88, and lymphotoxin drive TNF-independent intestinal epithelial tissue damageIulia Rusu, Elvira Mennillo, Jared L Bain, et al.Nature Biotechnology|October 21, 2025
Integrated epigenetic and genetic programming of primary human T cellsLaine Goudy, Alvin Ha, Ashir A Borah, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor functionVincent Allain, Allison G Rothrock, Pierre-Louis Bernard, et al.Biorxiv : the Preprint Server for Biology|December 25, 2025
Base-editing a single missense mutation in A20 enhances CAR-T cell efficacyAdam Blaisdell, Stefanie Bachl, Luis R Sandoval, et al.Nature|June 6, 2020
CRISPR screen in regulatory T cells reveals modulators of Foxp3Jessica T Cortez, Elena Montauti, Eric Shifrut, et al.Pageof 4